Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. | Takeda has named Julie Kim ...

“This deal mitigates the inherent execution risks of a first-time commercial launch, optimises the timing, and enhances the scope for peak potential sales of rusfertide,” he said. For ...

Beyond being a big deal for Takeda, which is the state’s largest ... the 16-story tower at 585 Kendall is one of the few major commercial projects underway in Greater Boston right now.

Amid a rapidly evolving macroenvironment, Takeda is changing up its R&D priorities and investment strategy. “There's an evolution of our economic model that starts with [the] IRA (Inflation ...

Takeda continues to advance multiple late-stage programs and is on track for three Phase 3 data readouts within the calendar year 2025. The company expects three regulatory filings in FY2025 ...

Takeda, founded in 1781 in Osaka, Japan, operates in about 80 countries. The company established a commercial presence in India 13 years ago in Gurugram, currently employing around 200 people.

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing continued advancement of its Growth & Launch ...